Isec Healthcare Intrinsic Value Calculation – ISEC HEALTHCARE Reports Fiscal Year 2023 Q2 Earnings Results for June 30, 2023
August 15, 2023
🌥️Earnings Overview
On August 11th 2023, ISEC HEALTHCARE ($SGX:40T) reported its earnings results for the second quarter of the fiscal year 2023 ending on June 30th 2023. Total revenue for the quarter was SGD 17.5 million, showing an 8.2% growth from the same period of the year before. Unfortunately, net income decreased by 12.9%, totalling SGD 2.8 million.
Share Price
The stock opened at SG$0.5 and closed at the same price, signifying a steady outlook for the company’s performance. The steady stock price was primarily attributed to the impressive financial results that the company released. ISEC HEALTHCARE’s strong financial performance for this quarter indicates that the company is on the right track in terms of its growth and progress. The company’s CEO expressed his enthusiasm for the results and his optimism for a strong future performance.
The shareholders of ISEC HEALTHCARE were pleased with these results as they reflect the company’s ability to continuously grow and meet its financial goals. Going forward, ISEC HEALTHCARE will continue to focus on expanding into new markets and leveraging new technologies to improve its operations and increase its profitability. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Isec Healthcare. More…
| Total Revenues | Net Income | Net Margin |
| 69.4 | 13.17 | 19.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Isec Healthcare. More…
| Operations | Investing | Financing |
| 17.3 | -8.02 | -11.18 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Isec Healthcare. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 103.33 | 23.54 | 0.14 |
Key Ratios Snapshot
Some of the financial key ratios for Isec Healthcare are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 22.8% | 38.8% | 26.3% |
| FCF Margin | ROE | ROA |
| 17.6% | 14.2% | 11.0% |
Analysis – Isec Healthcare Intrinsic Value Calculation
At GoodWhale, we analyse the financials of ISEC HEALTHCARE to determine its intrinsic value. Using our proprietary Valuation Line, we determined that the intrinsic value of the ISEC HEALTHCARE share is around SG$0.5. At the moment, ISEC HEALTHCARE’s stock is traded at SG$0.5, which is slightly overvalued by 10.2%. As such, it is currently considered a fair price. More…
Peers
ISEC Healthcare Ltd is an established healthcare provider in the industry, offering medical services and products to its customers. It faces competition from Chengdu Bright Eye Hospital Co Ltd, Republic Healthcare Ltd, and PT Sejahteraraya Anugrahjaya Tbk, all of which provide quality healthcare services in their respective regions. ISEC Healthcare Ltd strives to provide innovative solutions for its customers in order to remain competitive.
– Chengdu Bright Eye Hospital Co Ltd ($SZSE:301239)
Chengdu Bright Eye Hospital Co Ltd is a company based in Chengdu, China which specializes in medical services. As of 2023, the company has a market cap of 13.3 billion USD. This market cap indicates that the company is highly valued in the market and that investors have a lot of confidence in it. The company’s return on equity (ROE) of 5.03% further serves to demonstrate the company’s financial health and profitability. The company provides eye care services, including diagnosis, treatment and prevention, as well as related medical services, such as vision checkups, eyewear fitting and prescription sunglasses.
– Republic Healthcare Ltd ($SEHK:08357)
Healthcare Ltd is a leading healthcare and pharmaceutical company in the United Kingdom. The company provides services to a variety of customers including hospitals, health care professionals, and pharmaceutical companies. The company has a market capitalization of 139.78 million as of 2023, reflecting the value of its shares relative to the total market value of its outstanding shares. Its Return on Equity (ROE) stands at -6.07%, which is a measure of the company’s profitability and efficiency in deploying its shareholders’ equity. Healthcare Ltd is well positioned to take advantage of growth opportunities within the healthcare and pharmaceutical industry.
– PT Sejahteraraya Anugrahjaya Tbk ($IDX:SRAJ)
PT Sejahteraraya Anugrahjaya Tbk (PTSA) is an Indonesian investment holding company that specializes in the energy sector. The company has a market cap of 7.62T as of 2023, making it one of the largest publicly traded companies in the country. Its Return on Equity (ROE) is -0.89%, indicating that the company has not been generating sufficient profits from its investments. The market cap of PTSA indicates the company’s potential for growth, however the low ROE suggests that capital investments may need to be improved in order for the company to realize its potential.
Summary
Investors have been analyzing ISEC HEALTHCARE‘s earnings results for the fiscal year 2023 Q2 ending on June 30 2023. Total revenue increased by 8.2%, amounting to SGD 17.5 million, but net income declined by 12.9%, totalling SGD 2.8 million. This decline has led investors to be cautious when considering the stock as an investment, as any further falls in net income could be detrimental to returns. Despite this, investors are keeping an eye on ISEC HEALTHCARE to see if the company can turn around and achieve more favourable results in the future.
